Lipopolysaccharides

Drug Profile

Lipopolysaccharides

Latest Information Update: 23 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer Nonindustrial source
  • Class
  • Mechanism of Action Granulocyte colony stimulating factor stimulants; Immunomodulators; Interleukin stimulants; Tumour necrosis factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 10 Jan 1997 A study has been added to the therapeutic trials, adverse effects and immunogenicity sections
  • 09 Jan 1997 Phase-II clinical trials for Cancer in Germany (IV-injection)
  • 01 Aug 1996 Phase-I clinical trials for Cancer in Japan (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top